AR042015A1 - Marcador genetico relacionado con la capacidad de producir acido sulfhidrico para vacunas bacterianas atenuadas - Google Patents

Marcador genetico relacionado con la capacidad de producir acido sulfhidrico para vacunas bacterianas atenuadas

Info

Publication number
AR042015A1
AR042015A1 ARP030104114A ARP030104114A AR042015A1 AR 042015 A1 AR042015 A1 AR 042015A1 AR P030104114 A ARP030104114 A AR P030104114A AR P030104114 A ARP030104114 A AR P030104114A AR 042015 A1 AR042015 A1 AR 042015A1
Authority
AR
Argentina
Prior art keywords
ability
mutation
bacteria
bacterium
producing
Prior art date
Application number
ARP030104114A
Other languages
English (en)
Original Assignee
Avant Immunotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avant Immunotherapeutics Inc filed Critical Avant Immunotherapeutics Inc
Publication of AR042015A1 publication Critical patent/AR042015A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describen bacterias genéticamente alteradas atenuadas deficientes en la capacidad de producir sulfuro de hidrógeno (H2S) para utilizar como vacunas vivas o vectores vivos que pueden administrarse a un organismo huésped para proporcionar inmunidad frente a una enfermedad o para proporcionar otro producto o función genética beneficiosa. Las bacterias genéticamente alteradas de la presente pueden distinguirse fácilmente de otras bacterias mediante un fenotipo H2S negativo cuando se incuba en o de otro modo se contacta con un medio utilizado para detectar la producción de H2S en bacterias. Reivindicación 1: Una bacteria genéticamente alterada deficiente en la capacidad de producir sulfuro de hidrógeno (H2S) que comprende: (a) una primera mutación la cual atenúa la virulencia de dicha bacteria hacia un organismo huésped, donde dicha primera mutación no afecta la capacidad de dicha bacteria de producir H2S, y (b) una segunda mutación, donde dicha mutación torna a la bacteria deficiente en la capacidad de producir H2S.
ARP030104114A 2002-11-08 2003-11-07 Marcador genetico relacionado con la capacidad de producir acido sulfhidrico para vacunas bacterianas atenuadas AR042015A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42495202P 2002-11-08 2002-11-08

Publications (1)

Publication Number Publication Date
AR042015A1 true AR042015A1 (es) 2005-06-08

Family

ID=33551205

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104114A AR042015A1 (es) 2002-11-08 2003-11-07 Marcador genetico relacionado con la capacidad de producir acido sulfhidrico para vacunas bacterianas atenuadas

Country Status (3)

Country Link
AR (1) AR042015A1 (es)
AU (1) AU2003304255A1 (es)
WO (1) WO2005001069A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006095180A2 (en) * 2005-03-10 2006-09-14 Ultra Biotech Limited Humananized monoclonal antibodies against sars - associated coronavirus and treatment of patients with sars
WO2009025888A2 (en) 2007-05-10 2009-02-26 The Arizona Board Of Regents For And On Behalf Of Arizona State University Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety
WO2009046449A1 (en) 2007-10-05 2009-04-09 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against enteric pathogens
WO2010045620A1 (en) 2008-10-17 2010-04-22 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
US9163219B2 (en) 2009-04-14 2015-10-20 Arizona Board Of Regents On Behalf Of Arizona State University Single expression vector for generation of a virus with a segmented genome
WO2010135563A1 (en) 2009-05-22 2010-11-25 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium and methods of antigen and nucleic acid delivery
US9045742B2 (en) * 2009-05-29 2015-06-02 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant Edwardsiella bacterium
US9062297B2 (en) 2010-01-13 2015-06-23 The Arizona Board Of Regents For And On Behalf Of Arizona State University Yersinia pestis vaccine
WO2011091291A1 (en) 2010-01-22 2011-07-28 The Arizona Board Of Regents For And On Behalf Of Arizona State University BACTERIUM COMPRISING A REGULATED rfaH NUCLEIC ACID
CN101962625A (zh) * 2010-04-29 2011-02-02 河南科技大学 一种不含抗性标记的猪霍乱沙门氏菌基因缺失突变菌株及其疫苗
WO2011150421A2 (en) 2010-05-28 2011-12-01 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium to decrease tumor growth
US9303264B2 (en) 2012-05-18 2016-04-05 The Arizona Board Of Regents For And On Behalf Of Arizona State University Photosynthetic microorganisms expressing thermostable lipase
US9580718B2 (en) 2013-06-17 2017-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Attenuated live bacteria with increased acid resistance and methods of use thereof
CN104651288A (zh) * 2015-01-07 2015-05-27 四川农业大学 缺失crp的禽多杀性巴氏杆菌减毒菌株及其构建方法和应用
CN104560854B (zh) * 2015-01-07 2018-03-02 四川农业大学 缺失phoP的禽多杀性巴氏杆菌减毒菌株及其构建方法和应用

Also Published As

Publication number Publication date
AU2003304255A1 (en) 2005-01-13
WO2005001069A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
AR042015A1 (es) Marcador genetico relacionado con la capacidad de producir acido sulfhidrico para vacunas bacterianas atenuadas
Mobley et al. Helicobacter pylori: physiology and genetics
Salanitro et al. Isolation, culture characteristics, and identification of anaerobic bacteria from the chicken cecum
ES2061519T3 (es) Procedimiento para la produccion de acido eicosapentaenoico.
MX2011000793A (es) Metodos, sistemas y composiciones para incrementada tolerancia de microorganismos a y produccion de acido 3-hidroxipropionico (3-hp).
AR045813A1 (es) Metodo para obtener una toxina botulinica biologicamente activa, composicion que comprende clostridium botulinum y un medio de cultivo para producir una toxina botulinica mediante dicho metodo y metodo para preparar una composicion farmaceutica sustancialmente libre de producto animal en la que el i
ES2089232T3 (es) 5-enolpiruvilsiquimato-3-fosfato sintasas tolerantes del glifosato.
RU2008147883A (ru) Применение молочнокислых бактерий для уменьшения детской колики
CO5241327A1 (es) Nueva cepa lactobacillus que previene diarrea causada por bacterias patogenas
MX356086B (es) Produccion de acidos grasos y derivados de los mismos.
GB0103301D0 (en) Culture of crypthecodinium cohnii and microorganisms derived therefrom
Simon The role of Streptococcus mutans and oral ecology in the formation of dental caries
CN105925561A (zh) 一种耐强酸乳酸菌菌种的选育方法
CN102061272A (zh) 唾液乳杆菌株sil1及其应用
CN106282075A (zh) 一种用于培养副猪嗜血杆菌的液体培养基
Sánchez-Jiménez et al. Distribution of pathogenicity islands among Colombian isolates of Salmonella
DK1831349T3 (da) Fremgangsmåde til dyrkning af bakterier til afgivelse af bioaktive forbindelser til tarmen af drøvtyggere
US20150290257A1 (en) Method of enhancing hyaluronic acid secretion using probiotic strain
BRPI0401947A (pt) Método para produzir um l-aminoácido, e, bactéria
ES2365798T1 (es) Goma gelán genéticamente purificada.
CN103992962A (zh) 变异链球菌rnc基因突变株及其应用
Raut et al. Isolation and characterization of protease producing bacteria from upper respiratory tract of wild chicken
CN201813935U (zh) 杀菌鞋子
Kacou-N'douba et al. Antimicrobial resistance of Vibrio cholerae O1 isolated during a cholera epidemic in 2011 in dry season in Cote d’Ivoire
WO2007000332A3 (en) Biosynthetic process for the preparation of gallidermin

Legal Events

Date Code Title Description
FB Suspension of granting procedure